nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—KCND3—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0988	0.28	CbGpPWpGaD
Disopyramide—KCND2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0881	0.25	CbGpPWpGaD
Disopyramide—KCND3—Potassium Channels—KCNA4—thymus cancer	0.0507	0.144	CbGpPWpGaD
Disopyramide—KCND2—Potassium Channels—KCNA4—thymus cancer	0.0452	0.128	CbGpPWpGaD
Disopyramide—Abdominal bloating—Octreotide—thymus cancer	0.0424	0.0655	CcSEcCtD
Disopyramide—Epigastric pain—Octreotide—thymus cancer	0.0418	0.0645	CcSEcCtD
Disopyramide—Tingling sensation—Octreotide—thymus cancer	0.0251	0.0388	CcSEcCtD
Disopyramide—Numbness—Octreotide—thymus cancer	0.0244	0.0376	CcSEcCtD
Disopyramide—Sensory loss—Octreotide—thymus cancer	0.0233	0.036	CcSEcCtD
Disopyramide—Jaundice cholestatic—Octreotide—thymus cancer	0.023	0.0355	CcSEcCtD
Disopyramide—KCND3—Neuronal System—KCNA4—thymus cancer	0.0221	0.0628	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—KCNA4—thymus cancer	0.0197	0.0559	CbGpPWpGaD
Disopyramide—Gynaecomastia—Octreotide—thymus cancer	0.0181	0.0279	CcSEcCtD
Disopyramide—Cardiac failure congestive—Octreotide—thymus cancer	0.0162	0.025	CcSEcCtD
Disopyramide—Hypoglycaemia—Octreotide—thymus cancer	0.015	0.0232	CcSEcCtD
Disopyramide—Psychotic disorder—Octreotide—thymus cancer	0.0143	0.0221	CcSEcCtD
Disopyramide—Abdominal pain upper—Octreotide—thymus cancer	0.0134	0.0207	CcSEcCtD
Disopyramide—Muscular weakness—Octreotide—thymus cancer	0.0129	0.02	CcSEcCtD
Disopyramide—Abdominal distension—Octreotide—thymus cancer	0.0128	0.0197	CcSEcCtD
Disopyramide—Sweating increased—Octreotide—thymus cancer	0.0123	0.0191	CcSEcCtD
Disopyramide—Dysuria—Octreotide—thymus cancer	0.0118	0.0183	CcSEcCtD
Disopyramide—Pollakiuria—Octreotide—thymus cancer	0.0117	0.0181	CcSEcCtD
Disopyramide—Weight increased—Octreotide—thymus cancer	0.0115	0.0178	CcSEcCtD
Disopyramide—Drowsiness—Octreotide—thymus cancer	0.0113	0.0174	CcSEcCtD
Disopyramide—Depression—Octreotide—thymus cancer	0.0113	0.0174	CcSEcCtD
Disopyramide—Bradycardia—Octreotide—thymus cancer	0.0103	0.0159	CcSEcCtD
Disopyramide—Hepatitis—Octreotide—thymus cancer	0.0101	0.0157	CcSEcCtD
Disopyramide—Hypoaesthesia—Octreotide—thymus cancer	0.0101	0.0156	CcSEcCtD
Disopyramide—Arrhythmia—Octreotide—thymus cancer	0.00906	0.014	CcSEcCtD
Disopyramide—Flatulence—Octreotide—thymus cancer	0.0087	0.0134	CcSEcCtD
Disopyramide—Tension—Octreotide—thymus cancer	0.00866	0.0134	CcSEcCtD
Disopyramide—Nervousness—Octreotide—thymus cancer	0.00857	0.0132	CcSEcCtD
Disopyramide—Vision blurred—Octreotide—thymus cancer	0.00832	0.0129	CcSEcCtD
Disopyramide—Ill-defined disorder—Octreotide—thymus cancer	0.00819	0.0127	CcSEcCtD
Disopyramide—Malaise—Octreotide—thymus cancer	0.00796	0.0123	CcSEcCtD
Disopyramide—Vertigo—Octreotide—thymus cancer	0.00793	0.0123	CcSEcCtD
Disopyramide—Syncope—Octreotide—thymus cancer	0.00792	0.0122	CcSEcCtD
Disopyramide—Loss of consciousness—Octreotide—thymus cancer	0.00776	0.012	CcSEcCtD
Disopyramide—Chest pain—Octreotide—thymus cancer	0.00751	0.0116	CcSEcCtD
Disopyramide—Discomfort—Octreotide—thymus cancer	0.00742	0.0115	CcSEcCtD
Disopyramide—Dry mouth—Octreotide—thymus cancer	0.00735	0.0114	CcSEcCtD
Disopyramide—Oedema—Octreotide—thymus cancer	0.0072	0.0111	CcSEcCtD
Disopyramide—Shock—Octreotide—thymus cancer	0.00709	0.0109	CcSEcCtD
Disopyramide—Thrombocytopenia—Octreotide—thymus cancer	0.00705	0.0109	CcSEcCtD
Disopyramide—Skin disorder—Octreotide—thymus cancer	0.007	0.0108	CcSEcCtD
Disopyramide—Hyperhidrosis—Octreotide—thymus cancer	0.00696	0.0108	CcSEcCtD
Disopyramide—Anorexia—Octreotide—thymus cancer	0.00687	0.0106	CcSEcCtD
Disopyramide—Insomnia—Octreotide—thymus cancer	0.00652	0.0101	CcSEcCtD
Disopyramide—Paraesthesia—Octreotide—thymus cancer	0.00647	0.00999	CcSEcCtD
Disopyramide—Dyspnoea—Octreotide—thymus cancer	0.00642	0.00992	CcSEcCtD
Disopyramide—Somnolence—Octreotide—thymus cancer	0.0064	0.00989	CcSEcCtD
Disopyramide—Dyspepsia—Octreotide—thymus cancer	0.00634	0.0098	CcSEcCtD
Disopyramide—Decreased appetite—Octreotide—thymus cancer	0.00626	0.00967	CcSEcCtD
Disopyramide—Fatigue—Octreotide—thymus cancer	0.00621	0.00959	CcSEcCtD
Disopyramide—Constipation—Octreotide—thymus cancer	0.00616	0.00952	CcSEcCtD
Disopyramide—Pain—Octreotide—thymus cancer	0.00616	0.00952	CcSEcCtD
Disopyramide—SCN5A—Axon guidance—DPYSL5—thymus cancer	0.00596	0.0169	CbGpPWpGaD
Disopyramide—Feeling abnormal—Octreotide—thymus cancer	0.00594	0.00917	CcSEcCtD
Disopyramide—Urticaria—Octreotide—thymus cancer	0.00572	0.00884	CcSEcCtD
Disopyramide—Body temperature increased—Octreotide—thymus cancer	0.00569	0.0088	CcSEcCtD
Disopyramide—Asthenia—Octreotide—thymus cancer	0.00517	0.00798	CcSEcCtD
Disopyramide—Pruritus—Octreotide—thymus cancer	0.0051	0.00787	CcSEcCtD
Disopyramide—Diarrhoea—Octreotide—thymus cancer	0.00493	0.00761	CcSEcCtD
Disopyramide—Dizziness—Octreotide—thymus cancer	0.00476	0.00736	CcSEcCtD
Disopyramide—Vomiting—Octreotide—thymus cancer	0.00458	0.00708	CcSEcCtD
Disopyramide—SLC22A2—Neuronal System—KCNA4—thymus cancer	0.00456	0.0129	CbGpPWpGaD
Disopyramide—Rash—Octreotide—thymus cancer	0.00454	0.00702	CcSEcCtD
Disopyramide—Dermatitis—Octreotide—thymus cancer	0.00454	0.00701	CcSEcCtD
Disopyramide—Headache—Octreotide—thymus cancer	0.00451	0.00697	CcSEcCtD
Disopyramide—Nausea—Octreotide—thymus cancer	0.00428	0.00661	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—DPYSL5—thymus cancer	0.00425	0.0121	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—KCNA4—thymus cancer	0.00425	0.012	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—KIT—thymus cancer	0.00386	0.0109	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TP53—thymus cancer	0.00157	0.00446	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—thymus cancer	0.000314	0.00089	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—AKT1—thymus cancer	0.000247	0.0007	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAML2—thymus cancer	0.000244	0.000691	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAML2—thymus cancer	0.000243	0.000689	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAML2—thymus cancer	0.000241	0.000682	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2—thymus cancer	0.000148	0.000418	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2—thymus cancer	0.000147	0.000417	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2—thymus cancer	0.000146	0.000413	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2—thymus cancer	0.000134	0.00038	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2—thymus cancer	0.000134	0.000379	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2—thymus cancer	0.000132	0.000375	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KIT—thymus cancer	0.000112	0.000319	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KIT—thymus cancer	0.000112	0.000318	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KIT—thymus cancer	0.000111	0.000315	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—thymus cancer	8e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—thymus cancer	7.98e-05	0.000226	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2—thymus cancer	7.92e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—thymus cancer	7.9e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2—thymus cancer	7.89e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2—thymus cancer	7.81e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—thymus cancer	7.27e-05	0.000206	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—thymus cancer	7.24e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—thymus cancer	7.17e-05	0.000203	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—thymus cancer	5.94e-05	0.000169	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—thymus cancer	5.54e-05	0.000157	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—thymus cancer	5.12e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—thymus cancer	5.08e-05	0.000144	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—thymus cancer	5.07e-05	0.000144	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—thymus cancer	5.02e-05	0.000142	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—thymus cancer	4.29e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—thymus cancer	4.28e-05	0.000121	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—thymus cancer	4.24e-05	0.00012	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—thymus cancer	2e-05	5.67e-05	CbGpPWpGaD
